.png)
.png)
Paradromics CEO Matt Angle at NANS 2023
.png)
This week's North American Neuromodulation Society (NANS) annual meeting this week will feature the panel “Brain Computer Interface Use Case for Real World Data and Real World Evidence”, which will dive into physician, developer, and user perspectives on BCI.
Panelists include Matt Angle, CEO and Founder of Paradromics Inc.; Ian Burkhart, BCI Pioneer and President of the The Ian Burkhart Foundation; Michael Mager, Co-Founder and CEO of Precision Neuroscience; Devjani Saha, Director of Neurology Regulatory Affairs at MCRA; and Florian Solzbacher, Co-Founder and Chairman at Blackrock Neurotech. Moderators include Nandan Lad, Neurosurgeon at Duke Medical Center, and Benjamin Rapoport, Neurosurgeon and Co-Founder of Precision Neuroscience.
Details: i3 Ecosystem of Neuromodulation Program on Thursday, January 12 at 10:45 am
%20(1).svg)
Paradromics Accepted to FDA Regulatory Accelerator Program and Announces New Patient Registry
Paradromics CEO Matt Angle on the Neuralink Demo
Paradromics Raises $33 Million in Funding, Achieves Breakthrough Medical Device Designation from FDA
The Neurotech Revolution goes (back) to Washington!
.svg)